Stock listing
KRX:238120 Aligned Genetics, Inc. (얼라인드) 주가
Follow Aligned Genetics, Inc. into a list and get an email when it puts out news.
Share price · KRX:238120
₩2,945.00 KRW +165.00 (+5.9%)
Close on Nov 20, 2026
- Day range
- ₩2,845.00 – ₩2,945.00 KRWNov 20, 2026
- Volume
- 7,208 sharesNov 20, 2026
- Market cap
- ₩41.74B KRWAt the close on Nov 20, 2026 · price × 14.17M shares outstanding
- 52-week range
- ₩2,345.00 – ₩6,050.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩40.90M KRWMedian day 10,932 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:238120 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩2,945.00 | +165.00 | +5.9% | ₩2,845.00 | ₩2,945.00 | ₩2,845.00 | 7,208 | |
| ₩2,780.00 | +55.00 | +2.0% | ₩2,895.00 | ₩2,895.00 | ₩2,680.00 | 14,137 | |
| ₩2,725.00 | -70.00 | -2.5% | ₩2,760.00 | ₩2,850.00 | ₩2,695.00 | 25,099 | |
| ₩2,795.00 | +5.00 | +0.2% | ₩2,890.00 | ₩2,890.00 | ₩2,710.00 | 16,155 | |
| ₩2,790.00 | -5.00 | -0.2% | ₩2,800.00 | ₩2,835.00 | ₩2,770.00 | 7,300 | |
| ₩2,795.00 | +10.00 | +0.4% | ₩2,785.00 | ₩2,800.00 | ₩2,680.00 | 10,910 | |
| ₩2,785.00 | +70.00 | +2.6% | ₩2,745.00 | ₩2,790.00 | ₩2,640.00 | 17,727 | |
| ₩2,715.00 | +40.00 | +1.5% | ₩2,675.00 | ₩2,715.00 | ₩2,655.00 | 5,938 | |
| ₩2,675.00 | +25.00 | +0.9% | ₩2,650.00 | ₩2,690.00 | ₩2,580.00 | 5,532 | |
| ₩2,650.00 | 0.00 | 0.0% | ₩2,650.00 | ₩2,650.00 | ₩2,455.00 | 6,101 | |
| ₩2,650.00 | -35.00 | -1.3% | ₩2,655.00 | ₩2,685.00 | ₩2,560.00 | 25,407 | |
| ₩2,685.00 | -5.00 | -0.2% | ₩2,690.00 | ₩2,720.00 | ₩2,550.00 | 21,555 | |
| ₩2,690.00 | +60.00 | +2.3% | ₩2,600.00 | ₩2,690.00 | ₩2,565.00 | 10,107 | |
| ₩2,630.00 | +60.00 | +2.3% | ₩2,565.00 | ₩2,630.00 | ₩2,475.00 | 7,215 | |
| ₩2,570.00 | +90.00 | +3.6% | ₩2,595.00 | ₩2,595.00 | ₩2,455.00 | 10,983 | |
| ₩2,480.00 | +40.00 | +1.6% | ₩2,610.00 | ₩2,615.00 | ₩2,400.00 | 24,166 | |
| ₩2,440.00 | +5.00 | +0.2% | ₩2,435.00 | ₩2,460.00 | ₩2,375.00 | 20,403 | |
| ₩2,435.00 | -90.00 | -3.6% | ₩2,525.00 | ₩2,525.00 | ₩2,410.00 | 17,238 | |
| ₩2,525.00 | -40.00 | -1.6% | ₩2,615.00 | ₩2,615.00 | ₩2,500.00 | 1,006 | |
| ₩2,565.00 | +25.00 | +1.0% | ₩2,535.00 | ₩2,565.00 | ₩2,405.00 | 3,363 | |
| ₩2,540.00 | -15.00 | -0.6% | ₩2,600.00 | ₩2,600.00 | ₩2,505.00 | 6,517 | |
| ₩2,555.00 | +10.00 | +0.4% | ₩2,595.00 | ₩2,610.00 | ₩2,495.00 | 6,576 | |
| ₩2,545.00 | +10.00 | +0.4% | ₩2,600.00 | ₩2,600.00 | ₩2,480.00 | 10,954 | |
| ₩2,535.00 | 0.00 | 0.0% | ₩2,625.00 | ₩2,625.00 | ₩2,490.00 | 5,444 | |
| ₩2,535.00 | +55.00 | +2.2% | ₩2,560.00 | ₩2,630.00 | ₩2,455.00 | 17,874 | |
| ₩2,480.00 | -10.00 | -0.4% | ₩2,465.00 | ₩2,575.00 | ₩2,345.00 | 10,563 | |
| ₩2,490.00 | -35.00 | -1.4% | ₩2,560.00 | ₩2,590.00 | ₩2,485.00 | 9,111 | |
| ₩2,525.00 | -5.00 | -0.2% | ₩2,535.00 | ₩2,590.00 | ₩2,410.00 | 5,402 | |
| ₩2,530.00 | -130.00 | -4.9% | ₩2,660.00 | ₩2,660.00 | ₩2,500.00 | 21,811 | |
| ₩2,660.00 | -90.00 | -3.3% | ₩2,770.00 | ₩2,770.00 | ₩2,645.00 | 23,966 | |
| ₩2,750.00 | +55.00 | +2.0% | ₩2,700.00 | ₩2,840.00 | ₩2,670.00 | 25,987 | |
| ₩2,695.00 | 0.00 | 0.0% | ₩2,720.00 | ₩2,760.00 | ₩2,685.00 | 31,680 | |
| ₩2,695.00 | -50.00 | -1.8% | ₩2,770.00 | ₩2,770.00 | ₩2,695.00 | 17,304 | |
| ₩2,745.00 | -220.00 | -7.4% | ₩2,850.00 | ₩2,860.00 | ₩2,725.00 | 54,280 | |
| ₩2,965.00 | -75.00 | -2.5% | ₩2,975.00 | ₩3,005.00 | ₩2,950.00 | 69,313 | |
| ₩3,040.00 | +70.00 | +2.4% | ₩2,965.00 | ₩3,045.00 | ₩2,865.00 | 9,922 | |
| ₩2,970.00 | +5.00 | +0.2% | ₩2,970.00 | ₩3,000.00 | ₩2,875.00 | 8,246 | |
| ₩2,965.00 | +80.00 | +2.8% | ₩2,865.00 | ₩2,990.00 | ₩2,860.00 | 8,687 | |
| ₩2,885.00 | -105.00 | -3.5% | ₩3,020.00 | ₩3,020.00 | ₩2,875.00 | 12,987 | |
| ₩2,990.00 | -90.00 | -2.9% | ₩3,100.00 | ₩3,100.00 | ₩2,905.00 | 22,652 | |
| ₩3,080.00 | +45.00 | +1.5% | ₩3,055.00 | ₩3,125.00 | ₩3,000.00 | 14,387 | |
| ₩3,035.00 | +5.00 | +0.2% | ₩2,995.00 | ₩3,095.00 | ₩2,940.00 | 23,492 | |
| ₩3,030.00 | +95.00 | +3.2% | ₩2,930.00 | ₩3,030.00 | ₩2,840.00 | 15,186 | |
| ₩2,935.00 | -65.00 | -2.2% | ₩3,000.00 | ₩3,095.00 | ₩2,925.00 | 13,959 | |
| ₩3,000.00 | +60.00 | +2.0% | ₩2,940.00 | ₩3,045.00 | ₩2,795.00 | 17,506 | |
| ₩2,940.00 | -45.00 | -1.5% | ₩2,950.00 | ₩2,950.00 | ₩2,815.00 | 7,528 | |
| ₩2,985.00 | -10.00 | -0.3% | ₩2,995.00 | ₩3,040.00 | ₩2,785.00 | 17,198 | |
| ₩2,995.00 | +200.00 | +7.2% | ₩2,845.00 | ₩2,995.00 | ₩2,760.00 | 14,886 | |
| ₩2,795.00 | -50.00 | -1.8% | ₩2,810.00 | ₩2,860.00 | ₩2,785.00 | 10,545 | |
| ₩2,845.00 | -20.00 | -0.7% | ₩2,875.00 | ₩2,885.00 | ₩2,780.00 | 9,186 | |
| ₩2,865.00 | -10.00 | -0.3% | ₩2,875.00 | ₩2,880.00 | ₩2,850.00 | 2,131 | |
| ₩2,875.00 | -45.00 | -1.5% | ₩2,920.00 | ₩2,920.00 | ₩2,840.00 | 9,246 | |
| ₩2,920.00 | -45.00 | -1.5% | ₩2,965.00 | ₩2,990.00 | ₩2,875.00 | 7,612 | |
| ₩2,965.00 | -75.00 | -2.5% | ₩2,995.00 | ₩2,995.00 | ₩2,905.00 | 13,743 | |
| ₩3,040.00 | +60.00 | +2.0% | ₩2,990.00 | ₩3,050.00 | ₩2,900.00 | 4,482 | |
| ₩2,980.00 | +55.00 | +1.9% | ₩2,900.00 | ₩2,980.00 | ₩2,875.00 | 8,424 | |
| ₩2,925.00 | -50.00 | -1.7% | ₩2,920.00 | ₩2,945.00 | ₩2,855.00 | 47,134 | |
| ₩2,975.00 | -5.00 | -0.2% | ₩2,960.00 | ₩2,980.00 | ₩2,915.00 | 7,085 | |
| ₩2,980.00 | -45.00 | -1.5% | ₩2,960.00 | ₩3,005.00 | ₩2,910.00 | 12,054 | |
| ₩3,025.00 | +55.00 | +1.9% | ₩2,970.00 | ₩3,045.00 | ₩2,930.00 | 2,840 | |
| ₩2,970.00 | -115.00 | -3.7% | ₩3,010.00 | ₩3,020.00 | ₩2,930.00 | 7,041 | |
| ₩3,085.00 | +10.00 | +0.3% | ₩3,080.00 | ₩3,120.00 | ₩3,035.00 | 6,174 |
Splits
2 splits since 2020 · KRX:238120 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 2-for-1 | Split |
- Ticker
- KRX:238120
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
Aligned Genetics, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
Valuation
P/E 9.0× against a median of 23.6×: the lowest of 2 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩38.09B KRW
- P/E
- 9.0×
- EV/sales
- 2.4×
- EV/EBITDA
- 11.8×
- Price/book
- 1.1×
- Gross margin
- 73.5%
- Operating margin
- 15.6%
- Net margin
- 28.7%
- Debt to equity
- 0.3×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Aligned Genetics, Inc. · KRX:238120 | US$31.02M | US$28.31M | 9.0× | 2.4× | 11.8× | 1.1× | 28.7% | 0.3× | n/a |
| Trajan Group Holdings Ltd · ASX:TRJ | US$34.94M | US$64.98M | n/a | 0.6× | 7.6× | 0.5× | −0.4% | 0.6× | n/a |
| Novacyt SAS · EURONEXT:ALNOV | US$33.87M | US$35.59M | n/a | 0.8× | n/a | 1.4× | −102.4% | 0.6× | n/a |
| Rapid Micro Biosystems, Inc. · NASDAQ:RPID | US$33.56M | US$46.06M | n/a | 1.3× | n/a | 3.8× | −138.2% | 2.2× | 1.41 |
| Abnova Taiwan Corp. · TWSE:4133 | US$32.15M | US$20.35M | 23.6× | 1.9× | 13.4× | 0.8× | 13.0% | 0.0× | n/a |
| Precipio, Inc. · NASDAQ:PRPO | US$31.11M | US$27.88M | n/a | 1.0× | 119× | 2.1× | −4.1% | 0.0× | 1.00 |
| ENCell Co., Ltd. · KRX:456070 | US$30.74M | US$14.67M | n/a | 4.7× | n/a | 1.5× | −471.2% | 0.3× | n/a |
| LabTurbo Biotech Corporation · TPEX:7725 | US$29.75M | US$4.98M | n/a | n/a | n/a | 0.8× | n/a | 0.0× | n/a |
| BioMark Diagnostics, Inc. · CSE:BUX | US$29.71M | US$29.16M | n/a | 1,504× | n/a | 74.6× | n/a | 0.0× | -0.11 |
| Bio Preventive Medicine Corp. · TPEX:6810 | US$29.41M | US$26.21M | n/a | 329× | n/a | 3.7× | n/a | 0.4× | n/a |
| Abingdon Health PLC · LSE:ABDX | US$28.13M | US$26.14M | n/a | 1.8× | n/a | 3.5× | −19.4% | 0.2× | n/a |
| Median of the others | US$30.93M | US$27.05M | 23.6× | 1.8× | 13.4× | 1.8× | −19.4% | 0.3× | 1.00 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Jan 25, 2023 · Before open | −1.6% |
| Q3 2022 | Nov 14, 2022 · After close | +3.0% |
| Q2 2022 | Aug 16, 2022 · Before open | −1.8% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.0B | 15.8B | 15.2B | 13.8B | 11.8B | 7.96B | 7.79B | 5.68B | 5.64B | 4.71B |
| Cost of revenue | 4.79B | 4.62B | 4.54B | 4.99B | 4.42B | 3.41B | 3.18B | 2.32B | 2.04B | 2.19B |
| Gross profit | 11.2B | 11.2B | 10.7B | 8.77B | 7.35B | 4.54B | 4.61B | 3.36B | 3.60B | 2.52B |
| Research and development | 2.02B | 2.29B | 1.68B | 1.08B | 943.6M | 816.2M | 884.8M | 1.16B | 940.4M | 578.1M |
| Selling, general and administrative | 2.12B | 5.72B | 5.22B | 4.36B | 3.86B | 3.51B | 3.66B | 3.91B | 4.06B | 3.43B |
| Operating income | 2.44B | 2.78B | 3.34B | 2.85B | 2.18B | -253.5M | -398.9M | -1.92B | -1.85B | -1.67B |
| Depreciation and amortization | 609.0M | 548.1M | 596.2M | 650.4M | 538.6M | 676.1M | 716.4M | 487.4M | 419.5M | 136.4M |
| EBITDA | 3.05B | 3.33B | 3.93B | 3.50B | 2.72B | 422.6M | 317.4M | -1.44B | -1.43B | -1.54B |
| Interest expense | 103.9M | 169.1M | 214.9M | 166.0M | 28.9M | 82.8M | 118.6M | 0 | 0 | 0 |
| Income before tax | 2.65B | 4.54B | 3.42B | 2.44B | 3.81B | 468.2M | 116.7M | -1.59B | -1.75B | -1.56B |
| Income tax | 109.5M | -1.73B | ||||||||
| Net income | 2.91B | 4.13B | 3.24B | 2.33B | 5.54B | 468.2M | 116.7M | -1.59B | -1.75B | -1.56B |
| Earnings per share, basic | 207.10 | 287.09 | 225.05 | 162.23 | 385.40 | 65.13 | 16.24 | -220.89 | -244.02 | -218.38 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 14.6B | 8.33B | 14.9B | 9.44B | 5.28B | 5.64B | 4.90B | 2.87B | 7.41B | 9.31B |
| Short-term investments | 7.88B | 0 | 3.00B | 7.00B | 6.50B | 9.00B | 4.05B | 12.1B | 12.3B | |
| Receivables | 2.62B | 2.89B | 2.67B | 1.45B | 2.13B | 1.27B | 1.16B | 1.22B | 1.24B | 966.4M |
| Inventory | 4.98B | 4.20B | 3.85B | 3.76B | 2.35B | 2.11B | 2.12B | 2.15B | 1.36B | 1.71B |
| Current assets | 22.8B | 25.6B | 21.6B | 19.6B | 18.4B | 15.9B | 17.3B | 17.4B | 22.3B | 24.4B |
| Property, plant and equipment | 7.77B | 8.04B | 7.29B | 5.78B | 1.67B | 2.04B | 675.8M | 670.0M | 450.8M | |
| Total assets | 57.8B | 44.3B | 40.9B | 36.9B | 34.5B | 25.5B | 24.6B | 23.0B | 24.3B | 25.9B |
| Accounts payable | 153.7M | 97.5M | 164.9M | 134.3M | 144.5M | 278.4M | 157.4M | 72.5M | 41.8M | 83.0M |
| Current liabilities | 4.49B | 1.90B | 5.24B | 1.33B | 1.42B | 1.22B | 901.2M | 701.1M | 596.2M | 651.1M |
| Long-term debt | 11.8B | 2.40B | 0 | 3.90B | 3.90B | |||||
| Total debt | 916.8M | 994.0M | ||||||||
| Total liabilities | 20.6B | 8.78B | 9.62B | 8.05B | 7.48B | 4.02B | 3.65B | 2.11B | 1.67B | 1.68B |
| Shareholders' equity | 37.2B | 35.5B | 31.3B | 28.8B | 27.0B | 21.5B | 21.0B | 20.9B | 22.6B | 24.2B |
| Shares outstanding | 14.1M | 14.4M | 14.4M | 14.4M | 14.4M | 7.19M | 7.19M | 7.19M | 7.19M | 7.12M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 3.61B | 3.07B | 2.85B | 2.22B | 136.0M | 35.7M | 659.3M | -1.75B | -876.7M | -1.14B |
| Capital spending | -12.9B | -340.1M | -880.4M | -2.00B | -3.31B | -96.4M | -261.6M | -213.4M | -405.4M | -864.9M |
| Free cash flow | -9.30B | 2.66B | 1.97B | 218.8M | -4.73B | -69.8M | 133.5M | -1.96B | -1.28B | -2.01B |
| Cash from investing | -7.55B | 1.29B | 2.54B | -3.67B | 1.17B | 1.53B | -2.92B | -1.08B | -12.8B | |
| Cash from financing | -1.73B | -192.8M | -176.3M | 3.63B | -227.6M | -203.8M | -203.8M | 164.3M | 20.0B | |
| Share buybacks | -997.5M | 0 | 164.3M | 20.0B | ||||||
| Change in cash | 4.48B | -4.79B | 4.23B | 4.56B | 498.3M | 740.8M | 2.03B | -4.54B | -1.90B | 6.07B |
Cap table
Built by 6ix from Aligned Genetics, Inc.’s releases
- Common shares
- 14,172,274
- Fully diluted
- 14,172,274
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 14,172,274 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 14,172,274 |
Log in to ask 6ix AI your own questions about Aligned Genetics, Inc.